#4509 on the rich list of 14,644 insiders
John M. Evans
CEO at Beam Therapeutics. Based in Cambridge, Massachusetts.
$24.1M
in disclosed stock, −$81K (−0.33%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
- Rank
- 4509th of 14,644
- Companies held
- 1
- Largest holding
- BEAM, 100.0% of total
- Latest SEC filing
- Oct 16, 2026
What the $24.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Beam Therapeutics BEAM Common Stock | Directly | 1,047,205 | $20.94 | $21.9M | 91.0% | Form 4, Oct 16, 2026 |
| Beam Therapeutics BEAM Common Stock | Through John M. Evans, III 2018 Irrevocable Trust | 103,000 | $20.94 | $2.2M | 9.0% | Form 4, Oct 15, 2026 |
Share counts are the amounts John M. Evans reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Sold | BEAM | 25,000 | $23.98 | $600K | View |
| Oct 15, 2026 | Sold | BEAM | 25,000 | $23.57 | $589K | View |
| Jun 30, 2026 | Sold | BEAM | 23,100 | $34.26 | $791K | View |
| Jun 30, 2026 | Sold | BEAM | 1,900 | $34.84 | $66K | View |
| Jun 29, 2026 | Sold | BEAM | 11,579 | $35.91 | $416K | View |
| Jun 29, 2026 | Sold | BEAM | 13,421 | $35.13 | $471K | View |
| Apr 1, 2026 | Sold | BEAM | 30,078 | $24.58 | $739K | View |
| Mar 31, 2026 | Sold | BEAM | 25,000 | $22.76 | $569K | View |
| Mar 30, 2026 | Sold | BEAM | 25,000 | $22.37 | $559K | View |
| Jan 30, 2026 | Sold | BEAM | 2,906 | $29.00 | $84K | View |
| Jan 30, 2026 | Sold | BEAM | 22,094 | $28.27 | $625K | View |
| Jan 29, 2026 | Sold | BEAM | 16,333 | $29.19 | $477K | View |
| Jan 29, 2026 | Sold | BEAM | 8,667 | $29.74 | $258K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4506 | Christopher D. Farrar Chief Executive Officer, Velocity Financial. Westlake Village, CA | $24.1M |
| 4507 | Adam Pollitzer Chief Executive Officer, NMI Holdings. Emeryville, CA | $24.1M |
| 4508 | Scott M Shaw CEO, Lincoln Educational Services. Parsippany, NJ | $24.1M |
| 4509 | John M. Evans CEO, Beam Therapeutics. Cambridge, MA | $24.1M |
| 4510 | Roger C. Altman Founder and Senior Chairman, Evercore. New York, NY | $24.0M |
| 4511 | Felix The SVP Product & Technology, Grow, Unity Software. San Francisco, CA | $24.0M |
| 4512 | Chris Hulls Director, Life360. San Mateo, CA | $24.0M |
Other Beam Therapeutics insiders
All BEAM insiders- Giuseppe Ciaramella$5.3MPresident. #13852 overall
- Kristina Burow$545KDirector. #12282 overall
Questions
How much stock does John M. Evans own?
John M. Evans holds $24,085,293 in listed stock based on SEC filings and current prices, mostly Beam Therapeutics (BEAM). That ranks 4509th on the Stock Rich List.
Is this John M. Evans's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John M. Evans last buy or sell stock?
The most recent open-market trade on file is a sale of 25,000 BEAM shares on Oct 16, 2026 at $23.98.